hormone-therapy

Documents about hormone-therapy

• Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome#840868ClinicalTrials.gov
• Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer#805343ClinicalTrials.gov
• Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer#968862ClinicalTrials.gov
• Investigation of the Perceptual and Acoustic Voice in Trans Man#827775ClinicalTrials.gov
• Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation#883719ClinicalTrials.gov
• Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer#859234ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy#830776ClinicalTrials.gov
• Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients#828843ClinicalTrials.gov
• A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer#844627ClinicalTrials.gov
• Effects of Gender-Affirming Hormone Therapy Among Transgender Women#856984ClinicalTrials.gov
• D3-GHR Polymorphism and Turner Syndrome#866927ClinicalTrials.gov
• Endocrine Therapy Base on 21-gene RS#968756ClinicalTrials.gov
• Headache and Hormone Use Among Transgender Population in Thailand: A Cross-Sectional Online Study#979302ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy#847369ClinicalTrials.gov
• Associations of oral contraceptives and hormone replacement therapy with incident dementia risk: a population-based cohort study.#242148NCBI PubMed Central
• On Treating Athletes with Banned Substances: The Relationship Between Mild Traumatic Brain Injury, Hypopituitarism, and Hormone Replacement Therapy#750674PhilArchive
• A Menopause Interactive Decision Aid System#830397ClinicalTrials.gov
• Culturally Aware AET Non-Initiation Intervention#845156ClinicalTrials.gov
• Evaluation of rhGH Replacement Therapy in Patients With Pseudohypoparathyroidism Type Ia (PHP Ia)#874088ClinicalTrials.gov
• Wrist Cooling for Hot Flashes Clinical Trial#877017ClinicalTrials.gov
• Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm#913106ClinicalTrials.gov
• Supplementary Data for Injectable Estradiol Effectively Suppresses Testosterone in Gender-Affirming Hormone Therapy#1028156University of Virginia Dataverse Dataverse OAI Archive
• Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer#279582ClinicalTrials.gov
• First-line fulvestrant vs. anastrozole in hormone receptor-positive advanced breast cancer: insights from the final FALCON trial results#1001662OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• A perspective on economic barriers and disparities in access to hormone replacement therapy in LMICs (MARIE-WP2b).#305412NCBI PubMed Central
• Effect of Gender Affirming Hormone Therapy on Glucose Metabolism#828124ClinicalTrials.gov
• Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer#867300ClinicalTrials.gov
• Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer#918030ClinicalTrials.gov
• Pubertal Blockade and Hormone Therapy in Transgender Youth#969953ClinicalTrials.gov
• Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)#889752ClinicalTrials.gov
• A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer#287380ClinicalTrials.gov
• A Study:the Different Outcomes Between Natural Cycle and Hormone Replacement Cycle in FET#829054ClinicalTrials.gov
• Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles#311019ClinicalTrials.gov
• The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women#846882ClinicalTrials.gov
• Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer#1008826ClinicalTrials.gov
• Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer#855808ClinicalTrials.gov
• Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy#899231ClinicalTrials.gov
• Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy#915419ClinicalTrials.gov
• Experiences of autistic transgender and gender diverse adults undergoing gender-affirming hormone therapy and the influence on occupational identity outcomes.#785433NCBI PubMed Central
• Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer#838105ClinicalTrials.gov
• Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Neoadjuvant Trastuzumab Plus Pertuzumab#891617ClinicalTrials.gov
• Sleeping Through Menopause: study protocol of a randomized controlled trial of menopausal hormone therapy and online guided cognitive behavioural and circadian therapy for insomnia in perimenopausal women suffering from insomnia#451890Europe PMC
• Mat Pilates as a new approach for breast cancer patients undergoing hormone therapy: a randomized controlled clinical trial study protocol (HAPiMat Study)#487125SportRxiv
• A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer#460010ClinicalTrials.gov
• Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer#824836ClinicalTrials.gov
• Radiotherapy After Prostatectomy for Node Positive Prostate Cancer#852092ClinicalTrials.gov
• Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer#885276ClinicalTrials.gov
• Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)#196900Open Research
• Thyroid V40 as a potential early predictor of hypothyroidism following hypofractionated locoregional breast radiotherapy#292683PLOS
• Hormone Therapy is Associated with Better Cognitive Performance in Postmenopausal Women: Insights from the National Health and Nutrition Examination Survey (NHANES).#345151NCBI PubMed Central